Works by Ruiz‐Soto, Rodrigo

Results: 10

Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor α-targeting antibody-drug conjugate, in patients with solid tumors.

Published in:

2017

By:

Moore, Kathleen N.;
Borghaei, Hossein;
O'Malley, David M.;
Jeong, Woondong;
Seward, Shelly M.;
Bauer, Todd M.;
Perez, Raymond P.;
Matulonis, Ursula A.;
Running, Kelli L.;
Zhang, Xiaoyan;
Ponte, Jose F.;
Ruiz‐Soto, Rodrigo;
Birrer, Michael J.;
Ruiz-Soto, Rodrigo

Publication type:

journal article

Effects of CYP3A Inhibition, CYP3A Induction, and Gastric Acid Reduction on the Pharmacokinetics of Ripretinib, a Switch Control KIT Tyrosine Kinase Inhibitor.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1165, doi. 10.1002/cpdd.1110

By:

Li, Xiaoyan;
Shelton, Mark J;
Wang, Jing;
Meade, Julie;
Ruiz‐Soto, Rodrigo

Publication type:

Article

Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysis.

Published in:

Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 666, doi. 10.1177/1078155215603230

By:

Police, Rachel L.;
Trask, Peter C.;
Wang, Jianmin;
Olivares, Robert;
khan, Shahnaz;
Abbe, Adeline;
Colosia, Ann;
Njue, Annete;
Sherril, Beth;
Ruiz-Soto, Rodrigo;
Kaye, James A.;
Hamadani, Mehdi

Publication type:

Article

Clinical efficacy and safety in relapsed/refractory mantle cell lymphoma: a systematic literature review.

Published in:

2015

By:

Njue, Annete;
Colosia, Ann;
Trask, Peter C;
Olivares, Robert;
Khan, Shahnaz;
Abbe, Adeline;
Police, Rachel;
Wang, Jianmin;
Ruiz-Soto, Rodrigo;
Kaye, James A;
Awan, Farrukh

Publication type:

Journal Article

Clinical Efficacy and Safety in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Systematic Literature Review.

Published in:

2014

By:

Colosia, Ann;
Njue, Annete;
Trask, Peter C.;
Olivares, Robert;
Khan, Shahnaz;
Abbe, Adeline;
Police, Rachel;
Jianmin Wang;
Ruiz-Soto, Rodrigo;
Kaye, James A.;
Awan, Farrukh

Publication type:

Journal Article

Estimating late adverse events using competing risks after autologous stem‐cell transplantation in aggressive non‐Hodgkin lymphoma patientsThis study was presented in part at the American Society of Hematology 45th annual meeting, December 6–9, 2003, San Diego, California, USA.

Published in:

Cancer (0008543X), 2005, v. 104, n. 12, p. 2735, doi. 10.1002/cncr.21492

By:

Rodrigo Ruiz‐Soto;
Guillaume Sergent;
Christian Gisselbrecht;
Jerome Larghero;
Marjan Ertault;
Christophe Hennequin;
Julien Manson;
Eric de Kerviler;
Josette Briere;
Nicolas Mounier

Publication type:

Article

Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: analysis from the phase 3 INVICTUS trial.

Published in:

BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10379-9

By:

Schöffski, Patrick;
George, Suzanne;
Heinrich, Michael C.;
Zalcberg, John R.;
Bauer, Sebastian;
Gelderblom, Hans;
Serrano, César;
Jones, Robin L.;
Attia, Steven;
D'Amato, Gina;
Chi, Ping;
Reichardt, Peter;
Becker, Claus;
Shi, Kelvin;
Meade, Julie;
Ruiz-Soto, Rodrigo;
Blay, Jean-Yves;
von Mehren, Margaret

Publication type:

Article

Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study.

Published in:

Oncologist, 2021, v. 26, n. 11, p. e2053, doi. 10.1002/onco.13917

By:

Zalcberg, John R.;
Heinrich, Michael C.;
George, Suzanne;
Bauer, Sebastian;
Schöffski, Patrick;
Serrano, César;
Gelderblom, Hans;
Jones, Robin L.;
Attia, Steven;
D'Amato, Gina;
Chi, Ping;
Reichardt, Peter;
Somaiah, Neeta;
Meade, Julie;
Reichert, Vienna;
Shi, Kelvin;
Sherman, Matthew L.;
Ruiz‐Soto, Rodrigo;
von Mehren, Margaret;
Blay, Jean‐Yves

Publication type:

Article

A phase I open-label study of the safety, tolerability, and pharmacokinetics of pazopanib in combination with irinotecan and cetuximab for relapsed or refractory metastatic colorectal cancer.

Published in:

Investigational New Drugs, 2015, v. 33, n. 1, p. 138, doi. 10.1007/s10637-014-0142-1

By:

Bennouna, Jaafar;
Deslandres, Marion;
Senellart, Helene;
Labareyre, Cecile;
Ruiz-Soto, Rodrigo;
Wixon, Claire;
Botbyl, Jeff;
Suttle, A.;
Delord, Jean-Pierre

Publication type:

Article

Efficacy, safety, pharmacokinetics and pharmacodynamics of SAR245409 (voxtalisib, XL765), an orally administered phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor: a phase 1 expansion cohort in patients with relapsed or refractory lymphoma

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 6, p. 1763, doi. 10.3109/10428194.2014.974040

By:

Papadopoulos, Kyriakos P.;
Egile, Coumaran;
Ruiz-Soto, Rodrigo;
Jiang, Jason;
Shi, Weiliang;
Bentzien, Frauke;
Rasco, Drew;
Abrisqueta, Pau;
Vose, Julie M.;
Tabernero, Josep

Publication type:

Article